Exploring the TAS-120-205 Trial: Understanding FGFR2 Inhibitor Impact on Cholangiocarcinoma Treatment” By Steve|2024-10-13T19:18:56+13:00July 31st, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: 120-205, Clinical Trial, FGFR2, TAS, Tiaho| Read More 0
Meet GEM/CIS/DURVA: A Formidable Trio in the Fight Against Cancer By Steve|2024-10-13T19:18:59+13:00July 18th, 2024|Categories: All, Treatments, Trials & Studies, Z-Legacy|Tags: durvalumab, Gem/Cis/Durva| Read More 0
Bile Gone Bad: The Rising Incidence of Bile Duct Cancer – The Hidden Dangers within Bile Composition By Steve|2024-10-13T19:19:03+13:00July 9th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Unlocking the Power of Immunotherapy and Gem/Cis: A Strategic Battle Plan for Fighting Cholangiocarcinoma By Steve|2024-10-13T19:19:05+13:00July 8th, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: Gem/Cis/Durva, Gem/Cis/Keytruda| Read More 0
Defeating Biliary Tract Cancer with ARTEMIDE-Biliary01: A New Hope By Steve|2024-10-11T15:58:46+13:00July 2nd, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: ARTEMIDE-Biliary01, PD-1, PD-L1, Rilvegostomig, TIGIT| Read More 0
AMG193 Trial targets MTAP Loss By Steve|2024-10-11T15:58:53+13:00June 25th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: MTAP Loss| Read More 0